| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1299086A4 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1250140B1 Combination ofan abl-, pdgf-receptor- and/or kit receptor-tyrosine kinase inhibitor with an organic compound capable of binding to alpha1-acidic glycoprotein |
| 05/27/2009 | CN101443292A New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
| 05/27/2009 | CN101439168A Method for preparing medicinal preparation for treating split-hand/split-foot and tinea manus and pedis |
| 05/27/2009 | CN101439151A Medicament for treating beriberi |
| 05/27/2009 | CN101439119A External-use medicament for treating urticaria, eczema and skin pruritus |
| 05/27/2009 | CN101439115A External-use medicament for empyrosis |
| 05/27/2009 | CN101439114A Chinese medicine for treating burn and scald, and preparation method thereof |
| 05/27/2009 | CN101439112A Medicament for treating leukoderma |
| 05/27/2009 | CN101439104A Medicament for treating burn by 'dry, moistening, dressing' three in one bandaging method |
| 05/27/2009 | CN101439097A Medicament for treating burn and scald and preparation method thereof |
| 05/27/2009 | CN101439093A Use of flavones substance extracted from leaves of Broussonetia papyrifera in preparing medicament for resisting fungal infection of skin |
| 05/27/2009 | CN101439091A Agent for nursing eye skin by eliminating and alleviating cell fatigue of eye skin |
| 05/27/2009 | CN101439052A Cicada slough hypersusceptibility-dispelling granular formulation |
| 05/27/2009 | CN101439008A Women's washing lotion |
| 05/27/2009 | CN101439006A Application of 1-O-(4-hydroxy phenyl)-beta-D-ribofuranoside as tyrosinase inhibitor |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100490899C Pharmaceutical compositions |
| 05/27/2009 | CN100490889C Hair growing gel for pelada and lipsotrichia and its preparation |
| 05/27/2009 | CN100490888C Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria |
| 05/27/2009 | CN100490862C Preparation method of intestine-moistening face-beautifying granule and capsule with micron pine pollen, cactus, ganoderma lucidum and wolfberry fruit powder |
| 05/27/2009 | CN100490861C Preparation method of liver-benefiting face-beautifying wine with micron pine pollen and pearl powder for women |
| 05/27/2009 | CN100490860C Preparation method of liver-benefiting face-beautifying oral liquid with micron pine pollen and pearl powder for women |
| 05/27/2009 | CN100490851C Chinese-western medicine composition for treating acne |
| 05/27/2009 | CN100490848C Lotion of Chinese traditional medicine and preparation method |
| 05/27/2009 | CN100490819C Medicines of different characters and their preparation and use |
| 05/27/2009 | CN100490811C Piperazine derivative used as CCRS antagonist |
| 05/27/2009 | CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 05/27/2009 | CN100490791C Compositions and methods to treat neovascularization and disease associated with thereof |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538121 Vanilloid receptor modulators |
| 05/26/2009 | US7538100 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 05/26/2009 | US7537752 Mixture of chelate compound and active material in vehicle |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2494165C Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2465386C Use of glycosaminoglycans and zinc derivatives for insect bites, stings and the like |
| 05/26/2009 | CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 05/26/2009 | CA2455042C Method of reducing hair growth by applying alpha-difluoromethylornithine |
| 05/26/2009 | CA2454675C 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/26/2009 | CA2439671C Aquatic animal treatment method and composition containing pimenta extract |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 05/22/2009 | WO2009064493A1 Tricyclic compounds as melanogenesis modifiers and uses thereof |
| 05/22/2009 | WO2009064492A1 Quinoline compounds as melanogenesis modifiers and uses thereof |
| 05/22/2009 | WO2009064399A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | WO2009064023A1 Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063990A1 Benzazepinone compound |
| 05/22/2009 | WO2009063931A1 Method for evaluation of blood circulation-promoting activity, method for screening of blood circulation-promoting substance, and blood circulation promoter |
| 05/22/2009 | WO2009063897A1 Prophylactic or ameliorating agent for psoriasis in the skin |
| 05/22/2009 | WO2009063885A1 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan) |
| 05/22/2009 | WO2009063782A1 Composition for external application to skin |
| 05/22/2009 | WO2009063522A1 Composition for the treatment of hypertrophic scars comprising fucose, dimethylsulfone and/or acetyl glucosamine |
| 05/22/2009 | WO2009063492A2 Novel agents for treatment of ailments and dysfunctions |
| 05/22/2009 | WO2009063440A1 Compositions comprising stilbene polyphenol derivatives and use thereof for combating the ageing of living organisms and diseases affecting same |
| 05/22/2009 | WO2009063439A1 Compositions containing flavanoid polyphenol derivatives, and applications thereof in controlling diseases and ageing of living organisms |
| 05/22/2009 | WO2009063202A2 Use of crth2 antagonist compounds |
| 05/22/2009 | WO2009062313A1 Composition containing granulocyte colony stimulating factor (gcsf) for hair growth |
| 05/22/2009 | WO2009040552A3 Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof |
| 05/22/2009 | WO2009016629A3 Pharmaceutical composition for treating wounds and related methods |
| 05/22/2009 | CA2706557A1 Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter |
| 05/22/2009 | CA2705916A1 Benzazepinone compound |
| 05/22/2009 | CA2705840A1 Compositions comprising stilbene polyphenol derivatives and use thereof for combating the ageing of living organisms and diseases affecting same |
| 05/22/2009 | CA2705838A1 Compositions containing flavanoid polyphenol derivatives, and applications thereof in controlling diseases and ageing of living organisms |
| 05/22/2009 | CA2705539A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | CA2705372A1 Preventing or ameliorating agent for skin psoriasis |
| 05/22/2009 | CA2703109A1 Compositions and methods for treating purpura |
| 05/21/2009 | US20090131890 Protease inhibitors in absorbent articles |
| 05/21/2009 | US20090131537 Wound healing compositions |
| 05/21/2009 | US20090131521 Aqueous retinoid and benzoyl peroxide gel |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131438 Triazole derivative |
| 05/21/2009 | US20090131431 Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitors |
| 05/21/2009 | US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 05/21/2009 | US20090131404 Combinations |
| 05/21/2009 | US20090131397 Estrogen modulators |
| 05/21/2009 | US20090131381 Compositions comprising hydroquinone, fluocinolone acetonide and tretinoin for treating photoaging of the skin |
| 05/21/2009 | US20090131380 Novel pharmaceutical composition for topical treatment of skin psoriasis and the treatment method thereof |
| 05/21/2009 | US20090131378 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof |
| 05/21/2009 | US20090131375 Composition and method for treating skin |
| 05/21/2009 | US20090131340 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130239 Method for preventing or treating edema or dermatitis using glehnia littoralis fr. schmidt et miquel extract |
| 05/21/2009 | US20090130231 Pharmaceutical formulation for treating tinea of feet and hands and preparation thereof |
| 05/21/2009 | US20090130227 External preparation for skin |
| 05/21/2009 | US20090130223 Cosmetic preparation with aquaporin stimulators and the use thereof |
| 05/21/2009 | US20090130221 Decellularisation of tissue matrices for bladder implantation |
| 05/21/2009 | US20090130070 Method of treatment |
| 05/21/2009 | US20090130027 Compositions and methods for treating purpura |
| 05/20/2009 | EP2060582A1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |